Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smith & Nephew To Acquire Regenerative Shoulder-Tech Firm

Executive Summary

Th UK firm is buying Rotation Medical and its regeneration technology for shoulder rotator cuff repair for $125m, plus milestones, to grow its sports-medicine portfolio. The deal comes amid rumors that Smith & Nephew could be positioning itself to be acquired.

You may also be interested in...



Start-Up Spotlight: Miach’s BEAR Implant Helps Body Repair Torn ACL

Miach Orthopedics expects to soon earn US FDA de novo clearance for its Bridge-Enhanced ACL Repair (BEAR) technology as an alternative to conventional anterior cruciate ligament reconstruction surgery. Trials have shown BEAR helps restore torn ACLs to normal strength and function.

Stryker's Deal For Spine Device Maker Vexim Rounds Up Ortho M&A Trilogy

It's been a busy week for ortho M&A activity, with three key sector players cutting deals. Smith & Nephew's agreement to buy Rotation Medical kick-started the week, then two more deals followed in succession, with Exactech announcing it was to be acquired by private equity firm TPG Capital and Stryker saying it will acquire a majority control of Vexim, a French spinal device maker.

Rotation Medical: Healing Rotator Cuff Tears

Rotation Medical Inc.’s implantable collagen scaffold induces formation of new tendon-like tissue, and in some cases eliminates the need for suture anchors in surgical repair. This new technique has the potential to prevent rotator cuff disease progression and significantly reduce the incidence of re-tears.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121668

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel